Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias

Cardiovascular Research

Volumn 43, Issue 4, 1999, Pages 879-883

  Anvari, Anahit ^a   Türel, Zeynep ^a   Schmidt, Alice ^a   Yilmaz, Nilgün ^a   Mayer, Gert ^a   Huber, Kurt ^a   Schuster, E ^a   Gottsauner Wolf, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiotensin; Arrhythmia; Coronary disease; Receptor polymorphism; Renin angiotensin system

Indexed keywords

AGAROSE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; ARRHYTHMIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0344199926     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00143-1     Document Type: Article

References (31)

1. Linz W., Scholkens B.A. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. J Cardiovasc Pharmacol. 10:(Suppl 7):1987;75-82.
2. Bumpus F.M. Angiotensin I and II: some early observations made at the Cleveland Clinic Foundation and recent discoveries relative to angiotensin II formation in human hearts. Hypertension. 18:(suppl III):1991;III122-III125.
3. Noda K., Sasaguri M., Ideishi M., Ikeda M., Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res. 23:1993;334-340.
4. Rigat B., Hubert C., Alhence-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
5. Schunkert H., Hense H.W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
6. Raynolds M.V., Bristow M.R., Bush E.W., et al. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075.
7. Marian A.J., Yu Q., Workman R., Greve G., Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 342:1993;1085-1086.
8. Bonnardeaux A., Davies E., Jeunemaittre X., et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 24:1994;63-69.
9. Tiret L., Bonnardeaux A., Poirier O., et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type receptor gene polymorphism on risk of myocardial infarction. Lancet. 344:1994;910-913.
10. Alvarez R., Reguero J.R., Batalla A., et al. Angiotensin-converting enzyme and angiotensin II receptor 1 Polymorphism: association with early coronary disease. Cardiovasc Res. 40:1998;375-379.
11. Pye M.P., Cobbe S.M. Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res. 26:1992;740-750.
12. Webster M.W., Fitzpatrik M.A., Nocholls M.G., Ikram H., Wells J.E. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 56:1985;566-569.
13. Pomini G., Gribaldo R., Rugna A., Lupia M., Molfese G., Carenza P. Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure. G Ital Cardiol. 21:1991;59-65.
14. Cardiovasc Res. 35:1997;2-3.
15. Tiret L., Rigat B., Viskis S., et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-205.
16. Davies E., Bonnadeaux A., Lathrop G.M., et al. Angiotensin II (type-1) receptor locus: CA repeat polymorphism and genetic mapping. Hum Molec Genet. 4:1994;838.
17. Sochor H., Pachinger O., Ogris E., Probst P., Kaindl F. Radionuclide imaging after coronary vasodilatation, myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole. Eur Heart J. 5:1984;500-509.
18. Schmidt A., Kiener H.P., Barnas U., et al. Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol. 7:1996;314-317.
19. Castellano M., Muiesan M.L., Beschi M., et al. Angiotensin II type 1 receptor A/C1166 polymorphism, relationships with blood pressure and cardiovascular disease. Hypertension. 28:1996;1076-1080.
20. 2+ channel current by angiotensin II in rabbit ventricular myocytes. Circ. Res. 75:1994;1121-1125.
21. Harada K., Komuro I., Hayashi D., et al. Angiotensin II type 1a receptor is involved in the occurence of reperfusion arrhythmias. Circulation. 97:(4):1998;315-317.
22. Lakatta E.G. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation. 87:1993;631-636.
23. Grinstead W.C., Young J.B. The myocardial renin-angiotensin system: existence, importance, and clinical implications. Am Heart J. 123:1992;1039-1045.
24. Kleiger R.E., Miller J.P., Bigger J.T., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59:1987;256-262.
25. Joy M.D., Lower R.D. Evidence that area postrema mediates the central cardiovascular response to angiotensin II. Nature. 228:1970;1301-1304.
26. Weber K.T., Anversa P., Armstrong P.W., et al. Remodelling and reparation of the cardiovascular system. J Am Coll Cardiol. 20:1992;3-16.
27. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev. 69:1989;1049-1069.
28. Busjahn A., Voss A., Knoblauch H., et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms and heart rate variability in twins. Am J Cardiol. 81:1998;755-760.
29. Schieffer B., Wirger A., Meybrunn M., et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat. Circulation. 89:1994;2273-2282.
30. Pitt B., Segal R., Felip A.M., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study). Lancet. 349:1997;747-752.
31. Amant C., Hamon M., Bauters C., et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol. 29:1997;486-490.